Ramsell, a leading provider of innovative solutions for organizations that serve the underserved, today announced a new partnership with Alameda County Behavioral Health Care Services to provide pharmacy benefits management... Read more >>
Tuesday, October 8, 2013
Monday, October 7, 2013
With the enactment of the Affordable Care Act and recent launch of the state insurance exchanges, such as Covered California, there have been a number of questions regarding healthcare reform’s impact on federally-mandated healthcare programs, including the AIDS Drug Assistance Program (ADAP). Established in 1990 by the Ryan White Care Act, state ADAPs currently provide low-income people with access to life-saving HIV/AIDS treatment. Having managed ADAP programs around the country for more than 20 years, we have witnessed a lot of change and understand the importance of maintaining continuity of care as these programs evolve under healthcare reform. HIV patients that fall out of care can see a rapid advancement of the disease.
Wednesday, September 25, 2013
Thursday, August 22, 2013
The 340B conference held July 7-9, 2013 brought over a thousand attendees in what was considered, another successful and informative event. The HRSA recertification deadline and the Orphan Drug exclusion were the hot topics from the event.
The popularity of the 340B program further prompted discussions around audit and compliance and scrutiny from Congress and HRSA for program accountability. HRSA continues its plans to audit Covered Entities, with at least 30 audits completed so far this year, with many more expected before the end of the year.
Thursday, August 15, 2013
The 340B program's merit has consistently been scrutinized. Recent news suggests the 340B program is indeed beneficial to the healthcare society. Twenty-nine members of the senate are advocates of the program. Members of the house champion the 340B program and have concluded that the results indicate reduced pharmaceutical costs, to serve low-income patients and other vulnerable patients.